Learn effective strategies for protecting sensitive data in public disclosures while complying with regulations and maintaining clinical trial transparency. Join our expert panelists to discuss the CTIS/EU Clinical Trials Regulation, Policy 0070, and Health Canada’s data protection and privacy requirements. We will share best practices for data anonymization and redaction and industry survey results on managing CCI in public documents.
SPEAKERS
- THOMAS WICKS, Head of Transparency Operations, Citeline
- GREG SHEAR, Disclosure Services Lead, ClaritiDox
- ELLIOT ZIMMERMAN, CEO, Real Life Sciences
- PETER VINE, Head of Privacy for Norstella, Citeline
Related Resources